Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease prevalence » increased prevalence (Expand Search), disease prevalence (Expand Search), increasing prevalence (Expand Search)
gender decrease » greater decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 161 - 180 results of 6,206 for search '(( significant decrease prevalence ) OR ( significant ((gender decrease) OR (teer decrease)) ))', query time: 1.12s Refine Results
  1. 161
    Summary Statistics of the selected variables across 132 countries.

    Summary Statistics of the selected variables across 132 countries. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 162
    Model 2A results: Low volatility countries.

    Model 2A results: Low volatility countries. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 163
    Model 2B results: High volatility countries.

    Model 2B results: High volatility countries. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 164
    Variance inflation factors calculated for nine model variables included in the unrestricted model.

    Variance inflation factors calculated for nine model variables included in the unrestricted model. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 165
    Lifestyle and socioeconomic variables used in MLR models.

    Lifestyle and socioeconomic variables used in MLR models. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 166
    Cross correlation values of socioeconomic and lifestyle variables, for 132 countries and territories, colour coded by the degree of correlation (dark red coloured boxes represents strong positive correlation and dark blue coloured boxes represents strong anti-correlation).

    Cross correlation values of socioeconomic and lifestyle variables, for 132 countries and territories, colour coded by the degree of correlation (dark red coloured boxes represents... by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 167
    Model 1 regression results for unrestricted model.

    Model 1 regression results for unrestricted model. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 168
    Cross correlation matrix of socioeconomic and lifestyle variables, for 132 countries and territories.

    Cross correlation matrix of socioeconomic and lifestyle variables, for 132 countries and territories. by Selena E. Richards (1939318)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 169
    Demographics by Country and Gender.

    Demographics by Country and Gender. by Deeviya Francis Xavier (21485043)

    Published 2025
    “…Regarding creative self-efficacy, we found gender-specific impacts, with male participants experiencing a decrease, contrary to our expectations. …”
    Save to List
    Saved in:
  10. 170
    The difference in NCDs metabolic risk factors’ prevalence between the two surveys.

    The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

    Published 2024
    Save to List
    Saved in:
  11. 171
    Gender distribution of hookworm infections from 2016 to 2019 according to the national surveillance.

    Gender distribution of hookworm infections from 2016 to 2019 according to the national surveillance. by Hui-Hui Zhu (6506063)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 172
    Forest plot displaying <i>Strongyloides stercoralis</i> prevalence before and after the intervention (assessment with fecal tests), stratified by number of ivermectin rounds.

    Forest plot displaying <i>Strongyloides stercoralis</i> prevalence before and after the intervention (assessment with fecal tests), stratified by number of ivermectin rounds. by Giacomo Stroffolini (11716410)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 173
    Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter findings in 106 patients with acute Chagas disease acquired by the oral route, Chacao, Caracas, Venezuela, 2007–2017.

    Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter findings in 106 patients with acute Chagas disease acquired by the oral route, Cha... by Raiza Ruiz-Guevara (17108737)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 174
    Variations in the prevalence of OASI in France between 2010 and 2021 according to the classification for episiotomy practices.

    Variations in the prevalence of OASI in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 175
    Variations in the prevalence of episiotomy in France between 2010 and 2021 according to the classification for episiotomy practices.

    Variations in the prevalence of episiotomy in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 176
    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…The aim of this study was to define pooled prevalence estimate and correlates of VTE in Assigned Males at Birth (AMAB) trans people undergoing gender affirming hormone therapy.…”
    Save to List
    Saved in:
  17. 177
    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif

    Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

    Published 2021
    “…The aim of this study was to define pooled prevalence estimate and correlates of VTE in Assigned Males at Birth (AMAB) trans people undergoing gender affirming hormone therapy.…”
    Save to List
    Saved in:
  18. 178
    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx

    Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The aim of this study was to define pooled prevalence estimate and correlates of VTE in Assigned Males at Birth (AMAB) trans people undergoing gender affirming hormone therapy.…”
    Save to List
    Saved in:
  19. 179
    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The aim of this study was to define pooled prevalence estimate and correlates of VTE in Assigned Males at Birth (AMAB) trans people undergoing gender affirming hormone therapy.…”
    Save to List
    Saved in:
  20. 180
    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx

    Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

    Published 2021
    “…The aim of this study was to define pooled prevalence estimate and correlates of VTE in Assigned Males at Birth (AMAB) trans people undergoing gender affirming hormone therapy.…”
    Save to List
    Saved in:

Search Tools: